Macular Degeneration (Wet and Dry)
Maximum Award Level
$4,000Pharmacy Card Fund
Yes
Minimum CopayReimbursement Amount
Minimum Copay Reimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
None
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium Reimbursement Amount
Minimum Premium Reimbursement Amount
We encourage you to please submit monthly reimbursement claims (even if your premium is paid on a bi-weekly basis).
None
We encourage you to please submit monthly reimbursement claims (even if your premium is paid on a bi-weekly basis).
Household Income Limit
400% of the Federal Poverty Level(adjusted for household size and high
cost of living areas)
Treatments Covered
- Aflibercept
- Avastin
- Beovu
- Bevacizumab
- Bevacizumab-awwb
- Byooviz
- Cimerli
- Eylea
- Izervay
- Lucentis
- Macugen
- Mvasi
- Ozurdex
- Pegaptanib Sodium Injection
- Ranibizumab Injection
- Susvimo
- Vabysmo
- Verteporfin
- Visudyne
- Zirabev
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of wet or dry macular degeneration.
Grant Utilization
HealthWell estimates that patients use an average of $1,760 during their 12-month grant period for this disease area.
Consider Premium Assistance
Under this fund, HealthWell can assist with premium costs. Medicare supplemental policies can help with cost shares related to many aspects of your health care. Using a HealthWell grant to cover premiums may be a better option than treatment-specific cost shares.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
1.
You are being treated for Macular Degeneration.
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
-
2.
You have insurance and it covers your medication.
To qualify for assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.
-
3.
Your income falls within our guidelines.
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
4.
You are receiving treatment in the United States.
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Macular Degeneration
Macular Degeneration is caused by the deterioration of the central portion of the retina, the inside back layer of the eye that records the images we see and sends them via the optic nerve from the eye to the brain. The retina’s central portion, known as the macula, is responsible for focusing central vision in the eye, and it controls our ability to read, drive a car, recognize faces or colors, and see objects in fine detail. Source: American Macular Degeneration Foundation, National Eye Institute
Additional Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.